ESC 365 - Cystatin C-based estimated glomerular filtration rate to predict diuretic response to tolvaptan in acute decompensated heart failure

ESC Premium Access

Cystatin C-based estimated glomerular filtration rate to predict diuretic response to tolvaptan in acute decompensated heart failure

Session: New aspects of heart failure treatment

Topic: Pharmacotherapy

Speaker: Doctor K. Tsuchida (Niigata, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Keiichi Tsuchida

Niigata City General Hospital, Niigata (Japan)

0 follower

6 more presentations in this session

Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury

Speaker: Doctor T. Kambara (Seto, JP)

Full combination of guideline-recommended medical therapy is associated with better long-term mortality in acute heart failure patients with low blood pressure and renal dysfunction

Speaker: Doctor M. Kametani (Tokyo, JP)

Impact of catheter ablation for atrial fibrillation on clinical outcome in elderly patients hospitalized for acute heart failure

Speaker: Doctor M. Manita (Naha, JP)

Heart failure specialist nurse-led day case ambulatory management with intravenous diuretics reduces hospitalisations for acute decompensated heart failure irrespective of ejection fraction

Speaker: Mrs S. Hassan (Liverpool, GB)

Comparison of changes in the plasma volume and renal function between acetazolamide vs. conventional diuretics: understanding their mechanical differences according to the chloride theory

Speaker: Doctor H. Kataoka (Saiki, JP)

Access the full session

New aspects of heart failure treatment

Speakers: Doctor K. Tsuchida, Doctor T. Kambara, Doctor M. Kametani, Doctor M. Manita, Mrs S. Hassan...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources